DIXIE KNOLL: Open Payments
NPI 1235330390 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 36 payments from 21 companies in 2025. Trend: 2023 $251 · 2024 $264 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $178 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Janssen Biotech, Inc. | 3 | $78 |
| Incyte Corporation | 2 | $54 |
| Astellas Pharma US Inc | 2 | $52 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Novocure Inc. | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
Products named: ENHERTU, ERLEADA, ZYNLONTA, OPDIVO, XTANDI, Optune Lua (NovoTTF-200T), DATROWAY, KEYTRUDA.
Industry payments across ME — which companies pay providers there.
